SciSparc Signs Non-Binding Letter of Intent to Merge with Leading Vehicle Importer Company in Israel
SciSparc seeks to scale up revenues and will consider transferring its pharmaceutical activities to a separate legal entity and exploring...
Year: 2023
Lexicon Pharmaceuticals to Participate in the 35th Annual Piper Sandler Healthcare Conference and the 6th Annual Evercore ISI HealthCONx Conference
THE WOODLANDS, Texas, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the...
Syncona to Acquire Freeline Therapeutics
Freeline shareholders to receive $6.50 per American Depositary Share, a 51% premium over closing price prior to announcement of Syncona’s...
Redecan Cannabis Launches New Holiday Style Redees
Redecan’s Signature Redees Pre-rolls Get an Upgrade: New Sustainable Hemp Filters and Limited-Edition Holiday Style 10x0.4g Multi-Packs Now Available NationwideTORONTO,...
Werewolf Therapeutics to Present at the Evercore ISI HealthCONx Conference
WATERTOWN, Mass., Nov. 22, 2023 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical...
Axsome Therapeutics to Host Solriamfetol Virtual Investor Event on December 7
NEW YORK, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel...
Algernon Pharmaceuticals Announces LOI for the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position
VANCOUVER, British Columbia, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB:...
Entrada Therapeutics Announces Updates on ENTR-601-44 in Duchenne Muscular Dystrophy
– Company completes dosing of first and second cohorts in Phase 1 clinical trial, ENTR-601-44-101 – – ENTR-601-44 clinical development...
Press release Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion
PRESS RELEASE - 22 November 2023, 10:00 CET BIOCARTIS HOLDINGS INC. RECAPITALIZATION COMPLETED AND PRODUCT PORTFOLIO EXPANSION The recapitalization of...
Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023
GUANGZHOU, China, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or...
Mesoblast Partners With Blood and Marrow Transplant Clinical Trials Network (BMT CTN) on Pivotal Trial in Adults With SR-aGVHD
NEW YORK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
Relief Therapeutics Announces CEO Transition
GENEVA, SWITZERLAND / ACCESSWIRE / November 22, 2023 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical...
AlzeCure presents at Stora Aktiedagarna on November 27
STOCKHOLM, SE / ACCESSWIRE / November 22, 2023 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR),...
New EHR Integration Simplifies Provider Workflow for Patients Living With Diabetes
Tidepool announces new EHR integration tailored to accommodating health system-specific workflow requirementsPALO ALTO, Calif.--(BUSINESS WIRE)--#EHR--Tidepool, a software company committed to...
Sonendo, Inc. Announces Suspension of NYSE Trading, Will Commence Trading on the OTCQX Effective November 22, 2023
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX) (“Sonendo” or the “Company”), a leading dental technology company and developer of the...
Medicure Reports Financial Results for Quarter Ended September 30, 2023
WINNIPEG, MB / ACCESSWIRE / November 21, 2023 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused...
Tenon Medical Announces Closing of $1.25 Million Secured Note Financing
~ Provides Additional Liquidity to Augment Commercialization of Tenon's SI Joint Fusion Devices ~LOS GATOS, CA / ACCESSWIRE / November...
Diagnose Early Appoints New CEO and Chief Product Officer
Diagnose Early is delighted to welcome two highly experienced senior executives to our leadership team.MENLO PARK, CA / ACCESSWIRE /...
Cloud DX Will Report Third Quarter 2023 Results and Hold Earnings Call on Monday November 27, 2023
KITCHENER, ON / ACCESSWIRE / November 21, 2023 / Cloud DX (TSXV:CDX)(OTCQB:CDXFF), will post its Q3-2023 financial results after market...
New Study of an AI-Powered Spectroscopy Device Shows Promise for Skin Cancer Detection
MIAMI--(BUSINESS WIRE)--DermaSensor Inc. – Skin cancer is a global health concern, with increasing incidence rates worldwide. Artificial Intelligence (AI) is...